Guideline for procedure with suspektem and positive zytologischem reduction of the Cervix uteri;Guideline zum vorgehen bei suspektem und positivem zytologischem abstrich der Cervix uteri

Gynakologisch-geburtshilfliche Rundschau

Volumn 43, Issue 4, 2003, Pages 258-265

  Heinzl, S ^a  

^a Kantonsspital ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; DIAGNOSTIC APPROACH ROUTE; ENDOMETRIUM CYTOLOGY; GOOD LABORATORY PRACTICE; GYNECOLOGICAL EXAMINATION; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH PROMOTION; HUMAN; PAPANICOLAOU TEST; PERIODIC MEDICAL EXAMINATION; PRACTICE GUIDELINE; PUBLIC HEALTH SERVICE; REVIEW; RISK FACTOR; RISK MANAGEMENT; SEXUAL EDUCATION; SPECULAR MICROSCOPY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY;

EID: 0142038852     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072732     Document Type: Review

References (91)

1. Adam E, et al: Is human papillomavirus testing an effective triage method for detection of highgrade (grade 2 or 3) cervical intraepithelial neoplasia? Am J Obstet Gynecol 1998;178:1235-1244.
2. American College of Obstetricians and Gynecologists: Routine Cancer Screening. ACOG Committee Opinion No. 247. Washington, American College of Obstetricians and Gynecologists, 2000.
3. Andrae B, Smith P: Clinical impact of quality assurance in an organized cervical screening program. Acta Obstet Gynecol Scand 1999;78:429-435.
4. Autier P, Coibion M, de Sutter P, et al: Cytology alone versus cytology and cervicography for cervical cancer screening: A randomized study. Obstet Gynecol 1999;93:353-358.
5. Baldauf J-J, et al: An analysis of the factors involved in the diagnostic accuracy of colposcopically directed biopsy. Acta Obstet Gynecol Scand 1997;76:468-473.
6. Bertelsen B, Harveit F: The cervical smear record: The relevance to the subsequent development of cervical neoplasia. Acta Obstet Gynecol Scand 1995;74:729-733.
7. Boronow RC: Death of the Papanicolaousmear? A tale of three reasons. Am J Obstet Gynecol 1998;179:391-396.
8. Burger RA, et al: Single-visit program for cervical cancer prevention in a high-risk population. Obstet Gynecol 1995;86:491-498.
9. Burghardt E: Kolposkopie - Spezielle Zervix-pathologie. Stuttgart, Thieme, 1984.
10. American Cancer Society: Cervical cancer: Prevention and risk factors. http://www3.cancer.org/cancer-info. Accessed March 16, 2000.
11. Consensus Statement National Institutes of Health Consensus Development Conference Statement on Cervical Cancer. Gynecol Oncol 1997;66:351-361.
12. Cruickshank ME, Buchann S, Melvin W, et al: Human papillomavirus type 16 and 18 detection in the management of mild dyskaryosis. Br J Obstet Gynaecol 1999;106:969-976.
13. Cuzick J: Screening for cancer: Future potential. Eur J Cancer 1999;35:685-692.
14. De May RM: Common problems in Papanicolaou smear interpretation. Arch Pathol Lab Med 1997;121:229-238.
15. De Sutter P, et al: A multicentre study comparing cervicography and cytology in the detection of cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1998;105:613-620.
16. Duncan ID: Guidelines for Clinical Practice and Programme Management, ed 2. NHSCSP Publ No 8. Sheffield, NHSCSP, 1997.
17. Dunton CJ: New technology in Papanicolaou smear processing. Clin Obstet Gynecol 2000;43:410-417.
18. Eaker ED, et al: Cervical cancer screening among women with and without hysterectomies. Obstet Gynecol 1998;81:551-555.
19. Etherington IJ, et al: Video colpography: A new technique for secondary cervical screening. Br J Obstet Gynaecol 1997;104:150-153.
20. Fletcher A: Dealing with the report of a mild dyskaryotic smear. Br J Obstet Gynaecol 1995;102:517-519.
21. Franco E, Monsonego J: New Developments in Cervical Cancer Screening and Prevention. Oxford, Blackwell Science, 1997.
22. Genital infections and Neoplasia (update). Eurogin, issue 1, 1998.
23. Gitsch G, Kainz C: Diagnose und Therapie von zervikalen intraepithelialen Neoplasien. Speculum 1996;2:11-17.
24. Hartenbach EM, Schink JC: What to do about Pap smears: The Bethesda system. J Gynecol Tech 1999;5:7-10.
25. Heinrich J: Leitlinien der AG Zervixpathologie und Kolposkopie, Sektion der DGGG: Intraepitheliale Neoplasien und frühinvasive Karzinome des unteren Genitaltraktes der Frau (Cervix uteri, Vulva, Vagina). Zentralbl Gynäkol 1998;120:200-202.
26. Herbst AL, et al: Pathogenesis, detection and management of cervical neoplasia: A multi-disciplinary perspective. Am J Obstet Gynecol 1996;175(Suppl, Teil 2):4.
27. Hillemanns P, et al: Epidemiologie und Diag-nostik der zervikalen intraepithelialen Neoplasie - Ist das derzeitige Konzept von Screening und Diagnostik noch aktuell? Gynäkol Geburtshilfliche Rundschau 1997;37:179-190.
28. Holowaty P, Miller A, Rohan T, et al: Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-258.
29. Holzschneider C, Ghosh C, Montz F: See and treat in the management of high grade squamous intraepithelial lesions of the cervix: A resource utilization analysis. Obstet Gynecol 1999;94:377-385.
30. Jain AG, et al: Management of low-grade squamous intraepithelial lesions during pregnancy. Am J Obstet Gynecol 1997;177:298-302.
31. Jones HW III: Cervical intraepithel neoplasia. Clin Obstet Gynecol 1995;9:1.
32. Jones MH: The management of the mildly dyskaryotic smear. Br J Obstet Gynaecol 1994;101:474-476.
33. Jones HW: Clinical treatment of women with atypical squamous cells of undetermined signifiance or atypical glandular cells of undetermined significance cervical cytology. Clin Obstet Gynecol 2000;43:381-393.
34. Kaufman RH, et al: Analysis of atypical squamous (glandular) cells of undetermined significance smears by neural network - directed review. Obstet Gynecol 1998;91:556-560.
35. Kaufman RH, Adam E, Vonka V: Human papilloma virus infection and cervical carcinoma. Clin Obstet Gynecol 2000;43:363-380.
36. Kinney WK, et al: Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998;91:973-976.
37. Koss Leopold G: Reducing the error rate in Papanicolaou smears. Female Patient 1994;19:2-6.
38. Kurman RJ, et al: Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-1869.
39. Lambert B, Boivin Y, Lepage Y: Atypical squamous cells of undetermined significance (ASCUS): Clinical-cytological significance. Int J Gynecol Cancer 1999;9:329-332.
40. Lawson HW, et al: Cervical cancer screening among low-income women: Results of a national screening program, 1991-1995. Obstet Gynecol 1998;92:745-752.
41. Link M, Menton M: Zur Bedeutung der kolposkopischen Untersuchung bei der Früherkennung des Zervixkarzinoms (Wissenschaftlicher Stand vom Dezember 1996 und Ergebnis einer Konsensuskonferenz zu diesem Thema am 19.12.1996 in Frankfurt/Main). Frauenarzt 1998;39:380.
42. Lachmann MF, Cavallo-Calvanese C: Qualification of a typical squamous cells of undetermined significance in an independent laboratory: Is it useful or significant? Am J Obstet Gynecol 1998;179:421-429.
43. Liebermann R, Henry M, Laskin W, et al: Colposcopy in pregnancy: Directed brush cytology compared with cervical biopsy. Obstet Gynecol 1999;94:198-203.
44. Lörinez AT: Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am 1996;23:707-730.
45. Reid R: The management of genital condylomas, intraepithelial neoplasia, and vulvodynia. Obstet Gynecol Clin North Am 1996;23:917-991
46. Lonky N, et al: Low-grade Papanicolaou smears and the Bethesda system: A prospective cytohistopathologic analysis. Obstet Gynecol 1995;85:716-720.
47. Lonky N, Sadeghi M, et al: The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. Am J Obstet Gynecol 1999;181:560-564.
48. Luesley D, Jordan J, Richart RM: Intraepithelial Neoplasia of the Lower Genital Tract. London, Churchill Livingstone, 1995.
49. Luesley DM, et al: Cancer and Precancer of the Cervix. Edinburgh, Chapman & Hall Medical, 1998.
50. Manetta A, Keefe K, Lin F, et al: Atypical glandular cells of undetermined significance in cervical cytologic findings. Am J Obstet Gynecol 1999;180:883-888.
51. Manos M, Kinney W, Hurley L, et al: Identifying women with cervical neoplasia. JAMA 1999;281:1605-1610.
52. Meijer C, Helmerhorst T, Rozendaal L, et al: HPV typing and testing in gynaecological pathology: Has the time come? Histopathology 1998;33:83-86.
53. Matsuura Y, Kawagoe T, Toki N, Sugihara K, Kashimura M: Early cervical neoplasia confirmed by conization. Acta Cytol 1996;40:241-246.
54. Melnikow J, et al: Natural history of cervical squamous intraepithelial lesions: A meta-analysis. Obstet Gynecol 1998;92:727-735.
55. Mitchell MF, et al: Gynecologic cancer prevention. Obstet Gynecol Clin North Am 1996;23:2.
56. Mitchell MF, et al: Colposcopy for the diagnosis of squamous intraepithelial lesions: A meta-analysis. Obstet Gynecol 1998;91:626-631.
57. Mitchell MF, et al: A randomized clinical trial of cryotherapy, laser vaporisation and LOOP eletrosurgical excision for treatment of squamous intraepithelial lesion of the cervix. Obstet Gynecol 1998;92:737-744.
58. Monsonego J, et al: Cervical cancer control. General statements and guidelines. Eurogin - WHO International Joint Meeting, 1996.
59. Monsonego J: Screening of cervical cancer for whom, why and how? Experts' conference. Eurogin, 1994.
60. Montz FJ: Management of high grade cervical intraepithelial neoplasia and low grade squamous intraepithelial lesion and potential complications. Clin Obstet Gynecol 2000;43:394-409.
61. Ng TY: Pap Smear screening and cervical cancer. The Female Patient 1997;7:11-14.
62. Nieminen P, Kallio M, Hakama M: The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol 1995;85:1017-1021.
63. Olamijulo J, Duncan ID: Is cervical cytology screening of teenagers worthwhile? Br J Obstet Gynaecol 1995;102:515-516.
64. Patnick J: Report of Pre-Congress Seminar on the Organisation of Cervical Screening Programs. Eurogin, 1997.
65. Pinto AP, Crum CP: Natural history of cervical neoplasia: Defining progression and its consequence. Clin Obstet Gynecol 2000;43:352-362.
66. Prendiville W: Diagnosis and treatment of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1995;38:3.
67. Quinn P, Babb P, Jones J, et al: Effect of screening on incidence of and mortality from cancer of cervix in England: Evaluation based on routinely collected statistics. Br Med J 1999;318:904-908.
68. Ratschläge für die Praxis. Genitale HPV-Infektionen. Geburtsh Frauenheilkd 1994;12:179-183.
69. Richart RM, et al: Human papillomavirus. IAC task force summary. Acta Cytol 1998;42:50-58.
70. Roberts RA, Blunt SM: The psychological reaction of women to a colposcopy clinic. Br J Obstet Gynaecol 1994;101:751-752.
71. Rubin SC, Hoskins WJ: Cervical Cancer and Preinvasive Neoplasia. Philadelphia: Lippincott-Raven Publishers; 1996.
72. Sawaya GF, Washington AE: Cervical cancer screening: Which technique should be used and why? Clin Obstet Gynecol 1999;42:922-938.
73. Schenck U, et al: Terminology. IAC task force summary. Acta Cytol 1998;42:5-415.
74. Schneider D, Herrero R, Bratti C, et al. Cervicography screening for cervical cancer among 8,460 women in a higk-risk population. Am J Obstet Gynecol 1999;180:290-298.
75. Sigurdsson K: Cervical cancer, pap smear and HPV testing: An update of the role of organized Pap smear screening and HPV testing. Acta Obstet Gynecol Scand 1999;78:467-477.
76. Sigurdsson K: Trends in cervical intra-epithelial neoplasia in Iceland through 1995:Evaluation of targeted age groups and screening intervals. Acta Obstet Gynecol Scand 1999;78:486-492.
77. Sherlaw-Johnson C, Gallivan S, Jenkins D: Withdrawing low risk women from cervical screening programmes: Mathematical modelling study. Br Med J 1999;318:356-360.
78. Singer A, Monaghan JM: Lower Genital Tract Precancer. Oxford, Blackwell Science, 1994.
79. Shafi MI, et al: Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. Br J Obstet Gynaecol 1997;104:590-594.
80. Sherman ME, Kelly D: High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: Screening failures or rapid progression? Mod Pathol 1992;5:337-343.
81. Shingleton HM, Orr JW. Cancer of the Cervix. Philadelphia, Lippincott, 1995.
82. Solomon D, et al: ASCUS and AGUS criteria. IAC task force summary. Acta Cytol 1998;42:16-24.
83. Suh-Burgmann E, et al: Atypical squamous cells of undetermined significance: Management patterns at an academic medical center. Am J Obstet Gynecol 1998;178:991-995.
84. van Niekerk WA, et al: Colposcopy, cervicography, speculoscopy and endoscopy. IAC task force summary. Acta Cytol 1998;42:33-49.
85. Trimble E, Trimble C: Cancer: Obstetrics and Gynecology. Philadelphia, Lippincott Williams & Wilkins, 1999.
86. van Wijngaarden WJ, et al: Screening for cervical neoplasia in Dundee and Angus: 10 years on. Br J Obstet Gynaecol 1995;102:137-142.
87. Veljovich DS, et al: Atypical glandular cells of undetermined significance: A five-year retrospective histopathologic study. Am J Obstet Gynecol 1998;179:382-390.
88. Wertlake PT, et al: Effectiveness of the Papanicolaou smear and speculoscopy as compared with the Papanicolaou smear alone: a community-based clinical trial. Obstet Gynecol 1997;90:421-427.
89. Wildschut HIJ, et al: When to Screen in Obstetrics and Gynecology. London, Saunders, 1996.
90. Winter R, et al: Leitlinien für die operative Behandlung des Zervixkarzinoms erstellt von der Standardkommission der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe. Gynäkol Geburtshilfliche Rundsch 1997;37:227-229.
91. Yost N, Santoso J, McIntire D, et al: Postpartum regression of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol 1999;93:359-362.